EUVIMEDEUVIMED entdecken
Crossref

Cardiovascular risk profile in patients with hepatic steatosis

Angela Peltec, Victoria Ivanov, Ines Toaca, Sergiu Matcovschii

Moldovan Journal of Health Sciences · 2022

DOI: 10.52645/mjhs.2022.1.02 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Moldovan Journal of Health Sciences, 2022. Verfasst von Angela Peltec und 3 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 21 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background. Fatty liver disease (FLD) is composed of a wide spectrum including metabolic associated fatty liver disease (MAFLD). Cardiovascular disease (CVD) is the leading cause of mortality in this populational group. Many risk estimation systems are in existence for improving the management of population groups, but currently, none of the available risk prediction models are authenticated in patients with hepatic steatosis. Materials and methods. Transversal, observational, prospective, case control study has been included 680 patients with MAFLD and 96 control subjects without MAFLD. Experimental group was divided in tree subgroups: A - overweight or obesity (BMI ≥ 25 kg/m2 ) N= 498; B – lean/normal weight (BMI

Zitieren

APA

Peltec, A., Ivanov, V., Toaca, I., & Matcovschii, S. (2022). Cardiovascular risk profile in patients with hepatic steatosis. Moldovan Journal of Health Sciences. https://doi.org/10.52645/mjhs.2022.1.02

Vancouver

Peltec A, Ivanov V, Toaca I, Matcovschii S. Cardiovascular risk profile in patients with hepatic steatosis. Moldovan Journal of Health Sciences. 2022. doi:10.52645/mjhs.2022.1.02

BibTeX
@article{Peltec2022,
  author = {Peltec, Angela and Ivanov, Victoria and Toaca, Ines and Matcovschii, Sergiu},
  title = {Cardiovascular risk profile in patients with hepatic steatosis},
  journal = {Moldovan Journal of Health Sciences},
  year = {2022},
  doi = {10.52645/mjhs.2022.1.02}
}
Kostenlos starten →